 AUSTIN, TX ACCESSWIRE October 15, 2021 Apollo Endosurgery, Inc. Apollo NASDAQ:APEN, a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today the closing of its previously announced underwritten public offering. Apollo sold 9,660,000 shares of its common stock, including 1,260,000 shares sold pursuant to the underwriters exercise in full of their option to purchase additional shares, at a public offering price of 7.75 per share for gross proceeds of approximately 75 million, before deducting underwriting discounts and commissions and offering expenses. 